Surface Modified Nanoparticulate Carriers for the Targeted Treatment of Breast Cancer

  • Mishra N
  • Singh T
  • Nidhi
  • et al.
N/ACitations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Breast cancer left overs one of the greatest common metastasis disease in females. Advanced diagnostic devices and better understanding of tumour biology can extend the better therapeutic outcomes. Nanotechnology is a tool that helps in cancer diagnosis and treatment therapy. Many nanocarriers such as solid lipid nanoparticles, magnetic nanoparticles, nanocrystals, nanogels, nano-lipid nanocarriers, biodegradable nanoparticles, liposomes, and dendrimers are introduced to improve the therapeutic efficacy of antineoplastic agents. Surface modified target drug delivery system has the potential to increase the therapeutic effects and also reduce the cytotoxicity of breast cancer. Different approaches have been explored for treatment of breast cancer. This review describes the recent advances in the development of nanocarriers used for the targeted treatment of breast cancer. It also focuses on etiology, risk factor and conventional therapy of breast cancer. KEYWORDS: Breast Cancer; Nano-carriers; Tumor Targeting; Ligands; Receptor.

Cite

CITATION STYLE

APA

Mishra, N., Singh, T., Nidhi, Hallan, S. S., & Kaur, V. (2015). Surface Modified Nanoparticulate Carriers for the Targeted Treatment of Breast Cancer. International Journal of Pharmaceutical Sciences and Nanotechnology, 8(1), 2698–2714. https://doi.org/10.37285/ijpsn.2015.8.1.2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free